Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,237
Total Claims
$993K
Drug Cost
373
Beneficiaries
$2,662
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-34%
Opioid rate vs peers
2.5% vs 3.8% avg
+127%
Cost per patient vs peers
$2,662 vs $1,174 avg
+67%
Brand preference vs peers
14.8% vs 8.9% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.5%
Opioid Rate
255
Opioid Claims
$2,822
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,503 claims · $844K
Generic: 8,645 claims · $146K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 78 | $108K |
| Apixaban | 110 | $72K |
| Sitagliptin Phos/Metformin Hcl | 60 | $67K |
| Sitagliptin Phosphate | 47 | $54K |
| Linaclotide | 52 | $47K |
| Insulin Degludec | 21 | $36K |
| Empagliflozin | 24 | $29K |
| Semaglutide | 24 | $25K |
| Budesonide/Formoterol Fumarate | 59 | $24K |
| Rivaroxaban | 31 | $24K |
| Dapagliflozin Propanediol | 15 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $17K |
| Asenapine Maleate | 12 | $15K |
| Sacubitril/Valsartan | 18 | $15K |
| Insulin Detemir | 11 | $14K |
Prescribing Profile
Patient Profile
71
Avg Age
66%
Female
1.30
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About